Biotechnology Innovation Organization
BIO is the world's largest biotechnology organization, providing advocacy, business development, and communications services for more than 1,150 members worldwide. Corporate members range from entrepreneurial companies in the process of developing a first product to Fortune 100 multinationals. BIO also represents state and regional biotech associations, academic centers, and service providers to the industry.
Since BIO was formed in 1993, the biology-based, entrepreneurial industry has grown from a small number of companies concentrated in a few cities to an industry that increasingly extends throughout society. Nearly every state courts biotechnology development, as do an increasing number of countries around the world.
Advocating for Patient Access
State of Patient Access
Three Years In: Patient Access and the IRA
BIO2025: Humanity and Medicine
Welcome to BIO 2025!
Running on empty: Threats to early-stage drug development
Mission Moment
The Secret of Success: How to start - and Thrive - as a Patient Advocacy Organization
"Invest in America. Vaccinate."
Show Me the Evidence: Data to Understand and Break Down Patient Access Barriers!
Show Your Stripes: A Special Rare Disease Day Recap!
Patient Voice in CMS Drug Price "Negotiation"
Protecting Patient Access: Accelerated Approval
BIO 2025 Agriculture and Environment Summit Preview
PBM Coffee Chat (Full)
PBM Coffee Chat
The Faceless Middleman Between You and Your Doctor
The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab? (REDUX)
How Love Combined with Science Leads to Hope for Rare Disease
Patients Shaping Policy: CMS Engagement
How Will We Secure our Food Future?
Biotechnology is a National Security Asset
A Doctor Fights to Save His Own Life: The David Fajgenbaum Story.
What We Know About the Microbiome (REDUX)
Is CRISPR the New Sickle Cell Savior? (REDUX)
BIO Recognizes Industry Leaders for Groundbreaking Work in Agricultural, Environmental Biotech
BIO's President & CEO, John F. Crowley - BIO 2024
E&C Markup- Chairwoman Rodger-Pediatric Priority Review Voucher
John F. Crowley, President & CEO, BIO – The Hill -The Future of Cancer Care
John F. Crowley, President & CEO, BIO – 2024 MassBio State of Possible Conference